LDL receptor gene expression in human mesangial cells under the influence of calcium channel blockers

Clinical Nephrology

Volumn 51, Issue 5, 1999, Pages 263-271

  Ruan, X Z ^a   Varghese, Z ^a   Fernando, R ^a   Powas, S H ^a   Moorhead, J F ^a  

^a ROYAL FREE AND UNIVERSITY COLLEGE MEDICAL SCHOOL   (United Kingdom)

Author keywords

Calcium channel blocker; Glomerulosclerosis; Human mesangial cell; LDL receptor; LDL receptor gene promoter

Indexed keywords

CALCIUM CHANNEL BLOCKING AGENT; DILTIAZEM; LOW DENSITY LIPOPROTEIN; LOW DENSITY LIPOPROTEIN RECEPTOR; MESSENGER RNA; NIFEDIPINE; PROTEIN KINASE C; PROTEIN TYROSINE KINASE; VERAPAMIL;

ARTICLE; CELL PROLIFERATION; GENE EXPRESSION; HUMAN; HUMAN CELL; MESANGIUM CELL; NORTHERN BLOTTING; RECEPTOR GENE; SIGNAL TRANSDUCTION;

BLOTTING, NORTHERN; CALCIUM CHANNEL BLOCKERS; CELL DIVISION; CELLS, CULTURED; DILTIAZEM; GENE EXPRESSION; GLOMERULAR MESANGIUM; HUMANS; LIPOPROTEINS, LDL; NIFEDIPINE; RECEPTORS, LDL; RNA, MESSENGER; SIGNAL TRANSDUCTION; TRANSCRIPTION, GENETIC; VERAPAMIL;

EID: 0032940561     PISSN: 03010430     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (29)

1. Block LH, Matthys H, Emmons LR, Perruchoud A, Erne P, Roth M 1991 Ca(2+)-channel blockers modulate expression of 3-hydroxy-3-methylglutaryl-coenzyme A reductase and low density lipoprotein receptor genes stimulated by platelet-derived growth factor. Proc Natl Acad Sci USA 88: 9041-9045
2. Brown MS, Goldstein JL 1986 A receptor-mediated pathway for cholesterol homeostasis (Review). Science 232: 34-47
3. Chang R, Yang E, Chamblis D, KumarA, Wise J, Mehta KD 1996 In vivo role of the Sp1 site neighboring sterol-responsive element-1 in controlling low-density lipoprotein receptor gene expression. Biochem Biophys Res Commun 218: 733-739
4. Chirgwin JM, Przybyla AE, MacDonald RJ, Rutter WJ 1979 Isolation of biologically active ribonucleic acid from sources enriched in ribonuclease. Biochemistry 18: 5294-5299
5. Eckardt H, Filipovic I, Hasilik A, Buddecke E 1988 Calmodulin antagonists increase the amount of mRNA for the low-density-lipoprotein receptor in skin fibroblasts. Biochem J 252: 889-892
6. EL-Nahas AM, Marshall R, Moorhead JF 1983 Glomeruloatherosis or glomerulosclerosis. J Pathol 140: 155
7. Fernando RL, Varghese Z, Moorhead JF 1993 Oxidation of low-density lipoproteins by rat mesangial cells and the interaction of oxidised low-density lipoproteins with rat mesangial cells in vitro. Nephrol Dial Transplant 8: 512-518
8. Filipovic I, Buddecke E 1986 Calmodulin antagonists stimulate LDL receptor synthesis in human skin fibroblasts. Biochim Biophys Acta 876; 124-132
9. Filipovic I, Buddecke E 1986 Calcium channel blockers stimulate LDL receptor synthesis in human skin fibroblasts. Biochem Biophys Res Commun 136: 845-850
10. Goldstein JL, Basu SK, Brown MS 1983 Receptor-mediated endocytosis of low-density lipoprotein in cultured cells. Methods Enzymol 98: 241-260
11. Goldstein JL, Brown MS 1985 The LDL receptor and the regulation of cellular cholesterol metabolism (Review). J Cell Sci 3 (Suppl): 131-137
12. Grone EF, Abboud HE, Hohne M, Walli AK, Grone HJ, Stuker D, Robenek H, Wieland E, Seidel D 1992 Actions of lipoproteins in cultured human mesangial cells: modulation by mitogenic vasoconstrictors. Am J Physiol 263: F686-696
13. Haller H 1993 Calcium antagonists and cellular mechanisms of glomerulosclerosis and atherosclerosis (Review). Am J Kidney Dis 21: 26-31
14. Hoogerbrugge N, Jansen H, Stoels B, Kloet LT, Birkenhager JC 1996 Growth hormone normalizes low-density lipoprotein receptor gene expression in hypothyroid rats. Metabolism 45: 680-685
15. Hsu HY, Nicholson AC, Hajjar DP 1994 Basic fibroblast growth factor-induced low density lipoprotein receptor transcription and surface expression. Signal transduction pathways mediated by the bFGF receptor tyrosine kinase. J Biol Chem 269: 9213-9220
16. Kawabe Y, Honda M, Wada Y, Yazaki Y, Suzuki T, Ohba Y et al 1994 Sterol-mediated regulation of SREBP-1a,1b,1c and SREBP-2 in cultured human cells. Biochem Biophys Res Commun 202: 1460-1467
17. Lee HS, Koh HI 1994 Visualization of binding and uptake of oxidized low density lipoproteins by cultured mesangial cells. Lab Invest 71: 200-208
18. Moldeus P, Hogberg J, Orrenius S 1978 Isolation and use of liver cells. Methods Enzymol 52: 60-71
19. Moorhead JF, Chan MK, El-Nahas M, Varghese Z 1982 Lipid nephrotoxicity in chronic progressive glomerular and tubulo-interstitial disease. Lancet 2: 1309-1311
20. Nicholson AC, Hajjar DP 1992 Transforming growth factor-beta up-regulates low density lipoprotein receptor-mediated cholesterol metabolism in vascular smooth muscle cells. J Biol Chem 267: 25982-25987
21. Ruan XZ, Varghese Z, Fernando R, Moorhead JF 1998 Cytokine regulation of low-density lipoprotein receptor gene transcription in human mesangial cells. Nephrol Dial Transplant 13: 1391-1397
22. Sraer JD, Delarue F, Hagege J, Feunteun J, Pinet F, Nguyen G, Rondeau E 1996 Stable cell lines of T-SV40 immortalized human glomerular mesangial cells. Kidney Int 49: 267-270
23. Srivastava RA, Baumann D, Schonfeld G 1993 In vivo regulation of low-density lipoprotein receptors by estrogen differs at the post-transcriptional level in rat and mouse (published erratum appears in Eur J Biochem 1994 219: 1087). Eur J Biochem 216: 527-538
24. Srivastava RA, Ito H, Hess M, Srivastava N, Schonfeld G 1995 Regulation of low density lipoprotein receptor gene expression in HepG2 and Caco2 cells by palmitate, oleate, and 25-hydroxycholesterol. J Lipid Res 36: 1434-1446
25. Stopeck AT, Nicholson AC, Mancini FP, Hajjar DP 1993 Cytokine regulation of low density lipoprotein receptor gene transcription in HepG2 cells. J Biol Chem 268: 17489-17494
26. Streicher R, Kotzka J, Muller-Wieland D, Siemeister G, Munck M, Avci H, Krone W 1996 SREBP-1 mediates activation of the low density lipoprotein receptor promoter by insulin and insulin-like growth factor-I. J Biol Chem 271: 7128-7133
27. Sudhof TC, van der Westhuyzen DR, Goldstein JL, Brown MS, Russell DW 1987 Three direct repeats and a TATA-like sequence are required for regulated expression of the human low density lipoprotein receptor gene. J Biol Chem 262: 10773-10779
28. Takemura T, Yoshioka K, Aya N, Murakami K, Matumoto A, Itakura H, Kodama T, Suzuki H, Maki S 1993 Apolipoproteins and lipoprotein receptors in glomeruli in human kidney diseases. Kidney Int 43: 918-927
29. Weinstein DB, Heider JG 1989 Antiatherogenic properties of calcium antagonists. State of the art (Review). Am J Med 86: 27-32